Institutional Ownership
Lexicon Pharmaceuticals Inc
CUSIP 528872302COM NEWLXRXQ1 2026
13D / 13G Filings
23
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
36.2%
Max % of class reported
Institutional Holders
130
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
23 filings · latest Feb 2, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 2, 2026 | Invus, L.P. | 13D/A | 36.2% | — | SEC |
| 2 | Jul 8, 2025 | Fmr LLC | 13G/A | 10.5% | 38.14M | SEC |
| 3 | May 12, 2025 | Fmr LLC | 13G/A | 9.6% | 34.54M | SEC |
| 4 | Dec 9, 2024 | Invus, L.P. | 13D/A | 10.8% | 38.92M | SEC |
| 5 | Nov 14, 2024 | Biotechnology Value Fund L P | 13G/A | — | — | SEC |
| 6 | Nov 12, 2024 | Fmr LLC | 13G/A | 13.8% | — | SEC |
| 7 | Jul 29, 2024 | Invus, L.P. | 13D/A | 10.8% | 38.92M | SEC |
| 8 | Jul 10, 2024 | Fmr LLC | 13G | 10.7% | — | SEC |
| 9 | May 14, 2024 | Invus, L.P. | 13D/A | 10.8% | 38.92M | SEC |
| 10 | Mar 13, 2024 | Invus, L.P. | 13D/A | 15.8% | 38.92M | SEC |
13 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Lexicon Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Artal Group S.A. | 154.73M | $241.39M |
| 2 | Fmr LLC | 45.06M | $70.29M |
| 3 | Siren, L.L.C. | 44.30M | $69.11M |
| 4 | Sessa Capital Im, L.P. | 17.91M | $27.94M |
| 5 | Point72 Asset Management, L.P. | 7.81M | $12.19M |
| 6 | Millennium Management LLC | 4.94M | $7.71M |
| 7 | Blackrock, Inc. | 3.32M | $5.18M |
| 8 | Geode Capital Management, LLC | 3.17M | $4.95M |
| 9 | Jane Street Group, LLC | 2.67M | $4.16M |
| 10 | Ubs Group AG | 2.48M | $3.87M |